Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2006 1
2014 1
2015 1
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Mast cell sarcoma: clinical management.
Weiler CR, Butterfield J. Weiler CR, et al. Immunol Allergy Clin North Am. 2014 May;34(2):423-32. doi: 10.1016/j.iac.2014.01.004. Epub 2014 Mar 13. Immunol Allergy Clin North Am. 2014. PMID: 24745684 Review.
Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis. ...The prognosis of mast cell sarcoma in published literature is ve …
Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, …
Natural history and treatment of cutaneous and systemic mastocytosis.
Le M, Miedzybrodzki B, Olynych T, Chapdelaine H, Ben-Shoshan M. Le M, et al. Postgrad Med. 2017 Nov;129(8):896-901. doi: 10.1080/00325481.2017.1364124. Epub 2017 Aug 21. Postgrad Med. 2017. PMID: 28770635 Review.
INTRODUCTION: Mastocytosis, a heterogeneous group of disorders, is characterized by an abnormal increase in the number of mast cells that is limited to the skin (cutaneous mastocytosis), involving extracutaneous tissues (systemic mastocytosis), or presenting as solid tumou …
INTRODUCTION: Mastocytosis, a heterogeneous group of disorders, is characterized by an abnormal increase in the number of mast cells …
Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM, Torrelo A, Matito A. Azaña JM, et al. Actas Dermosifiliogr. 2016 Jan-Feb;107(1):15-22. doi: 10.1016/j.ad.2015.09.009. Epub 2015 Oct 30. Actas Dermosifiliogr. 2016. PMID: 26525106 Free article. Review. English, Spanish.
The systemic variants in this classification are as follows: indolent systemic mastocytosis (SM), aggressive SM, SM with an associated clonal hematological non-mast cell lineage disease, mast cell leukemia, mast cell sarcoma, and e …
The systemic variants in this classification are as follows: indolent systemic mastocytosis (SM), aggressive SM, SM with an associated clona …
Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A, Akin C, Valent P. Pardanani A, et al. Best Pract Res Clin Haematol. 2006;19(3):595-615. doi: 10.1016/j.beha.2005.07.010. Best Pract Res Clin Haematol. 2006. PMID: 16781490 Review.
Systemic mastocytosis (SM) is characterized by the abnormal growth and accumulation of mast cells (MC) in one or more organs. The interaction between the cytokine stem cell factor (SCF) and its cognate receptor, the c-kit receptor tyrosine kinase (KIT), plays a cent …
Systemic mastocytosis (SM) is characterized by the abnormal growth and accumulation of mast cells (MC) in one or more organs. The int …
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Valent P, et al. Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8. Leuk Res. 2001. PMID: 11377686 Review.
SM is further divided into the following categories: indolent systemic mastocytosis (ISM), SM with an associated clonal hematologic non-mast cell lineage disease (AHNMD), aggressive systemic mastocytosis (ASM), and mast cell leukemia (MCL). ...In typic …
SM is further divided into the following categories: indolent systemic mastocytosis (ISM), SM with an associated clonal hematologic non-m …
Systemic mastocytosis: current concepts and treatment advances.
Tefferi A, Pardanani A. Tefferi A, et al. Curr Hematol Rep. 2004 May;3(3):197-202. Curr Hematol Rep. 2004. PMID: 15087068 Review.
Systemic mastocytosis (SM), as opposed to cutaneous-only mastocytosis, implies the presence of neoplastic mast cell infiltration in extracutaneous tissue. Mast cell disease in adults is often systemic and often involves the bone marrow. ...SM may be in …
Systemic mastocytosis (SM), as opposed to cutaneous-only mastocytosis, implies the presence of neoplastic mast cell infiltrati …